RenBio is a New York-based biotechnology company that develops and commercializes therapies for the treatment of influenza and related diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address: 430 East 29th Street
City: New York
State: NY
Zip: 10016
Country: US
RenBio is a New York-based biotechnology company that develops and commercializes therapies for the treatment of influenza and related diseases.
Contact Phone:
+16464409411
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2020 | Equity | $14M | 5/2021 | Series A | 1 | $24M |
Ruentex Group Ruentex Group |
1/2021 | Venture Round | $14M | 10/2022 | Grant | 2 | $3M |
DARPA New York State Biodefense Commercialization Fund DARPA New York State Biodefense Commercialization Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|